These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 23636654
21. Clinical significance of subcutaneous fat and fascial involvement in juvenile dermatomyositis. Sakurai N, Hino-Shishikura A, Nozawa T, Kamide H, Ohara A, Nishimura K, Kikuchi M, Hara R, Mori M, Ito S. Mod Rheumatol; 2019 Sep; 29(5):808-813. PubMed ID: 30092673 [Abstract] [Full Text] [Related]
25. MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis. Ukichi T, Yoshida K, Matsushima S, Kawakami G, Noda K, Furuya K, Kurosaka D. RMD Open; 2019 Sep; 5(1):e000850. PubMed ID: 30997152 [Abstract] [Full Text] [Related]
26. Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool. Sanner H, Sjaastad I, Flatø B. Rheumatology (Oxford); 2014 Sep; 53(9):1578-85. PubMed ID: 24692575 [Abstract] [Full Text] [Related]
27. Whole-body MRI in suspected infant abuse. Perez-Rossello JM, Connolly SA, Newton AW, Zou KH, Kleinman PK. AJR Am J Roentgenol; 2010 Sep; 195(3):744-50. PubMed ID: 20729455 [Abstract] [Full Text] [Related]
28. Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. Varsani H, Charman SC, Li CK, Marie SK, Amato AA, Banwell B, Bove KE, Corse AM, Emslie-Smith AM, Jacques TS, Lundberg IE, Minetti C, Nennesmo I, Rushing EJ, Sallum AM, Sewry C, Pilkington CA, Holton JL, Wedderburn LR, UK Juvenile Dermatomyositis Research Group. Ann Rheum Dis; 2015 Jan; 74(1):204-10. PubMed ID: 24064003 [Abstract] [Full Text] [Related]
29. How Often are Pediatric Patients with Clinically Amyopathic Dermatomyositis Truly Amyopathic? Oberle EJ, Bayer ML, Chiu YE, Co DO. Pediatr Dermatol; 2017 Jan; 34(1):50-57. PubMed ID: 27813167 [Abstract] [Full Text] [Related]
30. Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire. Feldman BM, Ayling-Campos A, Luy L, Stevens D, Silverman ED, Laxer RM. J Rheumatol; 1995 Feb; 22(2):326-31. PubMed ID: 7738957 [Abstract] [Full Text] [Related]
31. Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies. Yao L, Yip AL, Shrader JA, Mesdaghinia S, Volochayev R, Jansen AV, Miller FW, Rider LG. Rheumatology (Oxford); 2016 Mar; 55(3):441-9. PubMed ID: 26412808 [Abstract] [Full Text] [Related]
32. Myofascia-dominant involvement on whole-body MRI as a risk factor for rapidly progressive interstitial lung disease in dermatomyositis. Karino K, Kono M, Kono M, Sakamoto K, Fujieda Y, Kato M, Amengual O, Oku K, Yasuda S, Atsumi T. Rheumatology (Oxford); 2020 Jul 01; 59(7):1734-1742. PubMed ID: 31925431 [Abstract] [Full Text] [Related]
33. Preliminary validation of muscle ultrasound in juvenile dermatomyositis (JDM). Mamyrova G, McBride E, Yao L, Shrader JA, Jain M, Yao J, Curiel RV, Miller FW, Harris-Love MO, Rider LG. Rheumatology (Oxford); 2022 Apr 18; 61(SI):SI48-SI55. PubMed ID: 34791066 [Abstract] [Full Text] [Related]
34. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, Garay S, Kuis W, Machado C, Pachman L, Prieur AM, Rider LG, Silverman E, Tsitsami E, Woo P, Giannini EH, Martini A, Paediatric Rheumatology International Trials Organization (PRINTO), Pediatric Rheumatology Collaborative Study Group (PRCSG). Rheumatology (Oxford); 2003 Dec 18; 42(12):1452-9. PubMed ID: 12832713 [Abstract] [Full Text] [Related]
35. Performance of an Automated Versus a Manual Whole-Body Magnetic Resonance Imaging Workflow. Stocker D, Finkenstaedt T, Kuehn B, Nanz D, Klarhoefer M, Guggenberger R, Andreisek G, Kiefer B, Reiner CS. Invest Radiol; 2018 Aug 18; 53(8):463-471. PubMed ID: 29697493 [Abstract] [Full Text] [Related]
36. Whole body muscle MRI protocol: pattern recognition in early onset NM disorders. Quijano-Roy S, Avila-Smirnow D, Carlier RY, WB-MRI muscle study group. Neuromuscul Disord; 2012 Oct 01; 22 Suppl 2():S68-84. PubMed ID: 22980770 [Abstract] [Full Text] [Related]
37. Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM). Abdul-Aziz R, Yu CY, Adler B, Bout-Tabaku S, Lintner KE, Moore-Clingenpeel M, Spencer CH. Pediatr Rheumatol Online J; 2017 Apr 12; 15(1):25. PubMed ID: 28403889 [Abstract] [Full Text] [Related]
38. Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis. Gitiaux C, De Antonio M, Aouizerate J, Gherardi RK, Guilbert T, Barnerias C, Bodemer C, Brochard-Payet K, Quartier P, Musset L, Chazaud B, Desguerre I, Bader-Meunier B. Rheumatology (Oxford); 2016 Mar 12; 55(3):470-9. PubMed ID: 26424834 [Abstract] [Full Text] [Related]
39. Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients. Mathiesen PR, Buchvald F, Nielsen KG, Herlin T, Friis T, Nielsen S. Rheumatology (Oxford); 2014 Apr 12; 53(4):644-9. PubMed ID: 24310298 [Abstract] [Full Text] [Related]
40. Whole-body magnetic resonance imaging of healthy volunteers: pilot study results from the population-based SHIP study. Hegenscheid K, Kühn JP, Völzke H, Biffar R, Hosten N, Puls R. Rofo; 2009 Aug 12; 181(8):748-59. PubMed ID: 19598074 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]